Center for Global Health R&D Policy Assessment

Follow us on:

Twitter

Posted by Gabrielle Partridge

Nov 2 2011

1 comment

Investing in an AIDS Vaccine for Sub-Saharan Africa—it just makes sense

An R4D paper emphasized the importance of investing in AIDS vaccine R&D

This is a joint post with Jared Augustein.

In the years since AIDS was first identified, it has killed over 30 million individuals. The thirtieth anniversary of AIDS offers a time to reflect on these tragic losses and reevaluate how we will continue to fight this disease in the upcoming years.

Connect

The Center's blog features news, announcements and opinion about the latest occurrences in global health R&D policy. The blog provides updates on our assessments, and we welcome your comments and insights. In addition to posts from the Center's own staff, the blog includes guest blogs from top global health R&D thinkers--funders, PDPs, industry folks, academics, policy makers and others. These posts aim to maintain a public conversation about how to accelerate global health R&D. If you're interested in contributing a guest blog, send us a note.

Blogs We Like

Global Health R&D Policy Assessment Center is a project of Results for Development, with funding from the Bill & Melinda Gates Foundation.

The Bill & Melinda Gates Foundation Results for Development Institute

Hide this

Need help?

Our blog features news and commentary about the latest occurrences in global health R&D. Scroll down the page to see previous posts.